Bradford LD - Search Results

1

Prevalence and correlates of depressive symptoms and resiliency among African American women in a community-based primary health care center.

Holden KB, Bradford LD, Hall SP, Belton AS. Holden KB, et al. Among authors: bradford ld. J Health Care Poor Underserved. 2013 Nov;24(4 Suppl):79-93. doi: 10.1353/hpu.2014.0012. J Health Care Poor Underserved. 2013. PMID: 24241263 Free PMC article.

2

Psychosocial and sociocultural correlates of depressive symptoms among diverse African American women.

Holden KB, Hall SP, Robinson M, Triplett S, Babalola D, Plummer V, Treadwell H, Bradford LD. Holden KB, et al. Among authors: bradford ld. J Natl Med Assoc. 2012 Nov-Dec;104(11-12):493-504. doi: 10.1016/s0027-9684(15)30215-7. J Natl Med Assoc. 2012. PMID: 23560351 Free PMC article.

3

Characterizing depression and comorbid medical conditions in African American women in a primary care setting.

Shim RS, Baltrus P, Bradford LD, Holden KB, Fresh E, Fuller LE Sr. Shim RS, et al. Among authors: bradford ld. J Natl Med Assoc. 2013 Summer;105(2):183-91. doi: 10.1016/s0027-9684(15)30106-1. J Natl Med Assoc. 2013. PMID: 24079219 Free PMC article.

4

High frequency of CYP2D6 poor and "intermediate" metabolizers in black populations: a review and preliminary data.

Bradford LD, Gaedigk A, Leeder JS. Bradford LD, et al. Psychopharmacol Bull. 1998;34(4):797-804. Psychopharmacol Bull. 1998. PMID: 10513455 Review.

5

CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants.

Bradford LD. Bradford LD. Pharmacogenomics. 2002 Mar;3(2):229-43. doi: 10.1517/14622416.3.2.229. Pharmacogenomics. 2002. PMID: 11972444 Review.

6

Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans.

Gaedigk A, Bhathena A, Ndjountché L, Pearce RE, Abdel-Rahman SM, Alander SW, Bradford LD, Rogan PK, Leeder JS. Gaedigk A, et al. Among authors: bradford ld. Pharmacogenomics J. 2005;5(3):173-82. doi: 10.1038/sj.tpj.6500305. Pharmacogenomics J. 2005. PMID: 15768052 Free PMC article.

7

CYP2D6*36 gene arrangements within the cyp2d6 locus: association of CYP2D6*36 with poor metabolizer status.

Gaedigk A, Bradford LD, Alander SW, Leeder JS. Gaedigk A, et al. Among authors: bradford ld. Drug Metab Dispos. 2006 Apr;34(4):563-9. doi: 10.1124/dmd.105.008292. Epub 2006 Jan 13. Drug Metab Dispos. 2006. PMID: 16415111

8

Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans.

Gaedigk A, Bradford LD, Marcucci KA, Leeder JS. Gaedigk A, et al. Among authors: bradford ld. Clin Pharmacol Ther. 2002 Jul;72(1):76-89. doi: 10.1067/mcp.2002.125783. Clin Pharmacol Ther. 2002. PMID: 12152006 Clinical Trial.

9

CYP2D6 poor metabolizer status can be ruled out by a single genotyping assay for the -1584G promoter polymorphism.

Gaedigk A, Ryder DL, Bradford LD, Leeder JS. Gaedigk A, et al. Among authors: bradford ld. Clin Chem. 2003 Jun;49(6 Pt 1):1008-11. doi: 10.1373/49.6.1008. Clin Chem. 2003. PMID: 12766015 No abstract available.

10

Identification and characterization of CYP2D6*56B, an allele associated with the poor metabolizer phenotype.

Gaedigk A, Eklund JD, Pearce RE, Leeder JS, Alander SW, Phillips MS, Bradford LD, Kennedy MJ. Gaedigk A, et al. Among authors: bradford ld. Clin Pharmacol Ther. 2007 Jun;81(6):817-20. doi: 10.1038/sj.clpt.6100125. Epub 2007 Mar 28. Clin Pharmacol Ther. 2007. PMID: 17392730

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters